Global Tissue Diagnostics Market 2016-2020

2016-02-24
Price :
Published : Feb-2016
No. of Pages : 72

Tissue diagnostics involves the diagnosis of diseases or analysis of the biological causes of the disease by extracting and analyzing a specific tissue. It has a broad range of applications in clinical research, clinical diagnostics, and cell biology. It is considered one of the most accurate techniques for the diagnosis of inflammatory conditions. Medical specialists particularly use tissue diagnostics in the area of molecular biology for cancer screening, therapy selection, diagnosis, and relapse monitoring. It helps in the screening and diagnosis of lymphoma, melanoma, leukemia, and breast, ovarian, cervical, head and neck, pancreatic, non-small cell lung, colorectal, brain, prostate, lung, and endometrial cancers. Pathologists use different technologies such as in situ hybridization (ISH), immunohistochemistry (IHC), special staining, and digital pathology and related methods including core biopsy, fine needle aspiration cytology, and open biopsy to study and diagnose cells.

The analysts forecast global tissue diagnostics market to grow at a CAGR of 11.59% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global tissue diagnostics market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of diagnostic devices based on the following techniques:

  • Advanced staining
  • Preanalytical and routine staining
  • Digital pathology

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

The report, Global Tissue Diagnostics Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the Key vendors operating in this market.

Key vendors

  • Abbott Diagnostics
  • Agilent Technologies (a parent company of Dako)
  • Danaher (a parent company of Leica Biosystems)
  • Roche Diagnostics

Other prominent vendors

  • 20/20 GeneSystems
  • Abcam
  • AdnaGen
  • Advanced Cell Diagnostics
  • Affymetrix
  • Agendia
  • AutoGenomics
  • AVIVA BioSciences
  • Biocare Medical
  • Biocartis
  • Cancer Genetics
  • ELITechGroup
  • Enzo Biochem
  • Epic Sciences
  • Fluidigm
  • HORIBA Medical
  • Janssen Diagnostics
  • Olympus Diagnostics Systems Group
  • Omnyx (a joint venture of GE Healthcare and the University of Pittsburgh Medical Center, US)
  • Oxford Gene Technology
  • PANAGENE
  • Protea Biosciences Group
  • Sakura Finetek

Market driver

  • Implementation by new customers
  • For a full, detailed list, view our report

Market challenge

  • Insurance coverage and reimbursement issues
  • For a full, detailed list, view our report

Market trend

  • Ready-to-use reagents
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the Key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?
Filed in: Diagnostics
Publisher : Technavio
More Reports
Title Price Buy Now

Global Immunodiagnostics Market 2017-2021

The global immunodiagnostics market is in the moderate growth stage. The integration of mature clinical chemistry analyzers and restricted specificity and sensitivity of immunoassays have generated demand for integrated immunochemistry analyzers. The increasing volume of tests conducted due to rise in laboratory consolidation has driven the trend of automated analyzers globally. The analysts forecast global immunodiagnostics market to grow at a CAGR of 7.80% during the period 2017-2021. Covered in this report This report covers the present scenario and the growth prospects of the global immunodiagnostics market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of immunodiagnostics devices.. The market is divided into the foll......
$3500

Global HPV Testing Market 2016-2020

According to Centers for Disease Control and Prevention (CDC), human papillomavirus (HPV) refers to a group of more than 100 related viruses that commonly cause infections and do not have any symptoms. Among these, more than 40 types of HPVs cause highly contagious diseases that are transmitted through direct sexual contact, infecting both male and female genitals. The other types of HPV cause non-genital warts that are not sexually transmitted. Though most HPV infections are harmless and heal on their own, certain high-risk types of genital HPV can be persistent and cause cervical, penile, anal, vaginal, and oropharyngeal cancers. Many individuals, especially women, undergo regular HPV tests as a preventive measure. HPV tests help to detect the viral genetic material in a cell sample take......
$2500

Global Blood Stream Infection Testing Market 2016-2020

The presence of bacteria and fungi in blood leads to blood stream infections. Bacteria and fungi enter into the blood and cause severe complications and infections such as pneumonia, meningitis, sepsis and AIDS. Bloodstream infections are caused when bacteria enter the bloodstream; this may occur through a wound, injection, or through a surgical procedure. Symptoms of bacteremia may include fever, chills, malaise, nausea, diarrhea, shortness of breath, and vomiting. This analysts forecast the global blood stream infection testing market to grow at a CAGR of 7.75% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global blood stream infection testing market for 2016-2020. To calculate the market size, the repo......
$2500

Global Professional Diagnostics Market 2016-2020

The global professional diagnostics market is expected to grow at a high rate in the forecast period. Factors such as increasing aging population and rise in incidence and prevalence of chronic diseases and infections are driving the market. Cancer, tuberculosis, malaria, diabetes, and cardiovascular diseases are the main factors for the increasingly diagnosed population. In addition, increasing public awareness, rapid technological innovations, product approvals from regulatory authorities, and new product launches are expected to have a positive impact on the market over the next few years. This analyst forecast the global professional diagnostics market to grow at a CAGR of 6.76% during the period 2016-2020. Covered in this report This report covers the present scenario and the......
$2500

Global Point-of-Care Coagulation Testing Market 2016-2020

Coagulation testing measures the ability of blood to form a clot. Clotting is the process of the blood converting from a liquid into a gel form. Coagulation tests are carried out to detect clotting disorders such as hemorrhage and thrombosis. Many types of coagulation tests exist, including complete blood count, factor V assay, fibrinogen level, PT, platelet count, TT, and bleeding time. The analysts forecast global point-of-care coagulation testing market to grow at a CAGR of 6.53% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global point-of-care coagulation testing market for 2016-2020. A 360-degree view of the market, based on products, application, and technology segments, has been considered for ma......
$2500

Global Enteric Disease Testing Market 2016-2020

Enteric diseases are infections caused by ingested bacteria and viruses. Direct contact with contaminated feces or vomit is the secondary mode of contracting enteric ailments. Symptoms of enteric diseases include stomach pain, vomiting, diarrhea, nausea, weight loss, anorexia, and fever. Enteric diseases may lead to stunted growth, malnutrition, and impaired cognitive development. Enteric disease testing is performed on individuals using rapid tests, culture tests, enzyme immunoassay tests, and immunoassay tests. The analysts forecast global enteric disease testing market to grow at a CAGR of 8.9% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global enteric disease testing market for 2016-2020. To calcula......
$2500

Global Gonorrhea Diagnostics Market 2016-2020

Gonorrhea is a sexually transmitted disease that can affect both males and females. It is caused by the bacterium Neisseria gonorrhoeae. The bacterium grows in warm and moist areas of uterus, reproductive tract, fallopian tubes, and urethra. It can also grow and infect the throat, mouth, and anus. Women are more likely to contract this disease than men. Based on the Sexually Transmitted Disease Surveillance 2009 report, the Centers for Disease Control and Prevention (CDC) estimated that gonorrhea is the second most common communicable disease in the US. The analysts forecast global gonorrhea diagnostics market to grow at a CAGR of 9.25% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the global gonorrhea diagn......
$2500

Global Transplant Diagnostics Market 2016-2020

Transplantation involves the transfer of cells, tissues, or organs from a donor to a recipient for restoring their function in cases of damage. Donor and recipient cells, tissues, and organs should match or be compatible, otherwise it can lead to transplant rejection. Human leukocyte antigens (HLAs) are present on the surface of the cells that regulate body recognition and reject foreign tissue transplants. In humans, major histocompatibility complex controlled by the genes located on chromosome 6 is responsible for ensuring compatibility between donors and recipients. The analysts forecast global transplant diagnostics market to grow at a CAGR of 6.63% during the period 2016-2020. Covered in this report The report covers the present scenario and the growth prospects of the global......
$2500

Global Rapid Diagnostics Market 2016-2020

Rapid diagnostic tests are diagnostic assays designed for low-resource settings that provide faster results. These can be carried out either at a patient's bedside or in a clinical setting. These devices are simple to operate and read, have a low cost, and are specific, sensitive, and stable at extreme temperatures. They also provide quick results. Rapid diagnostics is the fastest-growing segment in in vitro diagnostics (IVD). Rapid diagnostic tests include agglutination, lateral flow, flow through, solid phase, and nucleic-acid amplification tests. Diagnostic devices are used to detect and measure blood glucose and coagulation levels, cardiac biomarkers, infectious diseases, hemoglobin concentration, five-part differential blood count, and pregnancy and fertility status. These tests can b......
$2500

IVD Market in Europe 2016-2020

IVD tests help diagnose, monitor, and assess medical conditions, diseases, and infections in a controlled environment. These tests help in early diagnosis of diseases by enhancing control on test procedures and provide accurate results, leading to quality treatment and shorter hospital stays. They are also minimally invasive and help in lowering treatment costs. Manufacturers develop reagents, analytical instruments such as automated analyzers, and accessory products including software to measure the quality and parameters of samples. The analysts forecast IVD market in Europe to grow at a CAGR of 4.78% during the period 2016-2020. Covered in this report This report covers the present scenario and the growth prospects of the IVD market in Europe for 2016-2020. To calculate the mar......
$2500